INTRODUCTION
The abundance of the different polyunsaturated precursors for the different types of prostaglandins (monoenoic, dienoic and trienoic) in human tissues has recently received more attention following reports of the low incidence of acute myocardial infarction in Eskimos in Greenland (1,2). The markedly different pattern of fatty acid composition of the plasma lipids of Eskimos living in Greenland (3) relative to those living in Denmark strongly indicate beneficial effects of polyunsaturated acids derived from linolenate (e.g., timnodonic acid [20:5(n-311 that are so abundant in the Eskimo maritime food) (4) . A possible effect of linolenate in reducing coronary occlusion was reported and retracted 10 years earlier by Owren (5, 6, 7) . Dietary linolenate is rapidly converted in animal tissues to the long-chain forms, 20 :5, 22:5 and 22:6, which are then accumulated in cellular glycerolipids.
Thus., some antithrombotic effects reported (5) may be due to the longer C-20 and C-22 polyunsaturated derivatives of the (n-3) class of acids rather than the nutrient linolenate per se. Polyunsaturated acids of the (n-3) type do not stimulate platelet aggregation (8, 9) in contrast to the dramatic action of arachidonate [20:4(n-6) ] in producing stroke in rats (10) and sudden death in rabbits (11) . This action of arachidonate seems due to its ability to form thromboxane AP (12) . The additional action of thromboxane AP in causing thrombosis and arterial vasospasm (12) (13) (14) gives further impetus to understanding the manner in which certain C-20 and C-22 polyunsaturated acids may influence these fatal cardiovascular events. Dyerberg and Bang (1) indicated that the antiaggregatory action of 20:5(n-3) might be due to a competitive inhibition that prevents 20:4 from forming TXA2. This is in accord with an earlier reportthatfatty acids of the (n-3) type were not effectively oxidized by cylooxygenase from sheep vesicular gland (15). The (n-3) acids were bound to the active site with affinities (1.7 to 15)~M) equal to or greater than that for arachidonate and are thus effective competitive inhibitors (15). Moncada and Vane (16) agreeing with this concept and citing the evidence by Raz (17) have concluded that the use of eicosapentaenoate could afford a "dietary protection against thrombosis". Nevertheless, they regarded the protection to be due primarily to the possibility that [20:5(n-3)l can be utilized by the vessel wall to make "an antiaggregating substance, probably a A17-prostacyclin (PGI37" and an accompaning thromboxane A3 which is not a "proaggregatory agent". A recent report from Needleman's laboratory using 14C-20:5, emphasized the lower reaction rate with 20:5 (18) refocusing attention upon the ability of the (n-3) type of acids to inhibit cyclooxygenase.
A variety of fatty acids may be oxidized via the cyclooxgenase enzyme, and as a result, it lacks absolute specificity [reviewed in (19)l. The possibility of an exceptionally potent PGI3 being formed in Eskimos raised again the recurring question of whether or not trienoic prostaglandins occur to an appreciable extent in Nature.
Toward that objective, we reexamined the ability of cyclooxygenase from sheep vesicular gland to oxidize 20:5(n-3) and form the intermediate PGH3, necessary for subsequent prostacyclin or thromboxane production.
Our results, confirming an important inhibitory role for the (n-3) fatty acids, indicate a striking dependence of PGH3 biosynthesis upon the prevailing peroxide tone.
METHODS AND MATERIALS
Pure cyclooxygenase from sheep vesicular gland was prepared via DEAE cellulose and Bio-Gel column chromatography and isoelectric focusing as described earlier (20). The purified cyclooxygenase was dialyzed overnight in 0.2M phosphate buffer with 20% glycerol to remove phenol. Its concentration, expressed as nanomolar (nM), is based upon the subunit weight of 70,000 daltons (20). The activity of the enzyme was routinely determined polarigraphically in 3 ml reaction vessels containing 40i_rMarachidonate [20:4(n-6)l and 0.67mM phenol in O.lM Tris-HCl (pH 8.5) at 30 2 0.5'C. Instantaneous velocities were monitored using a Yellow Springs Model 53 oxygen meter in conjunction with an electror differentiator which provided a direct recording of the rate of oxygen utilization (21) when testing the effectiveness of different substrates.
After the reaction ceased due to enzymatic self-inactivation (22), a second addition of cyclooxygenase was made. Finally, excess lipoxygenase was added to the chamber to provide complete oxidation of the fatty acid and serve as control in making quantitative estimates of the extent of the reaction.
Eicosatrienoate [20:3(n-6)l and eicosatetraenoate [20:4(n-6)] were obtained as 99% pure from Nuchek Preps (Elysian, MN) and stored in toluene at O'C. The methyl ester of eicosapentaenoate [20:5(n-3)], obtained as 99% pure from Applied Sciences Lab (State College, PA) was saponified to obtain thefree acid. The methyl ester was dissolved in methanol, 2.7M KOH was added, and the solution was heated at 50°C for 30 minutes.
The solution was acidified with formic acid and the free acid was extracted with pentane. The pentane solution was evaporated under nitrogen, and the residue dissolved in chloroform and stored at 5°C. Aqueous solutions were prepared by evaporating aliquots of the stock acid solutions and dissolving the suspensions by vigorous shaking in O.lM Tris-HCl each fatty acid used for gas chromatography after derivative.
buffer (pH 8.5). The purity of enzymatic studies was confirmed by converting it to the methyl ester RESULTS Using 1OliM fatty acids in the standard assay conditions with 108nM cyclooxygenase, we observed utilization rates of 223 and 251 I-IM/min with [20:3(n-6)l and [20:4(n-6) 1, respectively, and 0 for [20:3(n-3) 1 and [20:5(n-3) 1. Table 1 illustrates further results for the two (n-3) acids in comparison with [20:4(n-6) ] in the presence and absence of 0.67mM phenol a peroxidase cosubstrate that helps lower the hydroperoxide content. Neither of the (n-3) acids was effectively oxidized by 25nM cyclooxygenase in the Presence ic of phenol, although they reacted completely with soybean lipoxyqenase.
In contrast to the (n-3) acids, 3 and 1OuM amounts of 20:4(n-6) were completely oxidized by the first addition of cyclooxygenase, with the 30uM experiment indicating 16uM was oxidized per 25nM enzyme (about 650 moles per mole of enzyme).
On the other hand, 20:3(n-3) was not oxidized significantly by cyclooxygenase under either condition.
In the absence of phenol, the extent of oxidation of [20:4(n-611 (about 4uM, limited by enzymatic self-inactivation) was about 3-fold greater than that for 20:5(n-3) (about 1.2~M). This represents about 150 and 50 molecules of substrate oxidized per molecule of enzyme subunit for 20 :4(n-6) and 20:5(n-3) respectively.
Under these conditions, the [20:4(n-611 reacted only twice as fast as the 20:5(n-3) . To examine the effect of peroxide tone upon the selectivity of the cyclooxygenase reaction, a moderate amount of glutathione peroxidase was added to systems containing 0.5mM glutathione to remove any excess hydroperoxides from the system. The amount of peroxidase added (5,000 units) was not enough to significantly inhibit the oxidation of 20:4-(n-6) in the absence of phenol or to inhibit the reaction of lipoxygenase with the acids. The results without added peroxidase (Table II) agreed well with those in experiments in Table I , with 20:4(n-6) reacting twice as fast as 20:5-(n-3) and to about a 3-fold greater extent.
In the presence of glutathione peroxidase, however, 20:5(n-3) was ineffective until the second addition of enzyme, where the extent of reaction with 301_1M substrate was much greater with the second addition.
DISCUSSION
Our results indicate that the peroxide tone can have a dramatic influence upon the specificity of cyclooxygenase action.
Oxidation of 20:5(n-3) does not proceed well in the presence of either the peroxidase cosubstrate, phenol, or with an active glutathione peroxidase system. The level of peroxidase activity used in our in vitro studies was much less than that present in liver cell mvo, and its effective inhibition suggest that similar inhibition would occur in many other tissues.
This phenomenon may have a decisive role in suppressing the conversion of eicosapentaenoic acid [20:5(n-3) ] into the trienoic prostaglandin derivative in vivo. A relatively low degree of conversion would be in accord with the finding that the (n-3) fatty acids can not relieve the inadequate reproductive capacity of rats deficient in essential fatty acids (23) (24) (25) . The different cyclooxygenase specificities that we have observed help highlight the need to examine cyclooxygenase activity under conditions similar to those that occur in vivo rather than systems with high peroxide contents generated vitro (26,271. In particular, the formation of trienoic!rostaglandin derivatives in a tissue may prove to be a very sensitive indicator of the prevailing abundance of peroxides.
It may occur to a greater extent in phagocytic cells that generate high peroxide tone.
Previous inhibitory studies with the (n-3) class of fatty acids (15) were performed with added 0.67mM phenol, and showed only the competitive reversible effect. We now recognize some conditions under which such acids may be oxygenated and thereby cause irreversible inactivation of the cyclooxygenase.
The inactivating conditions may have been obtained in incubations described earlier by Pace-Asciak and Wolfe (28) We have also observed a self-catalyzed inactivation with a variety of (n-6) fatty acids even in the presence of phenol (15). Inactivation with 20:2(n-6) occurred with only oneeighth the total oxygenation occurring with 20:4(n-6) (29). The extent of oxygenation with lO@l 20:5(n-3) upon a second addition of enzyme (0.9 PM) in the presence of glutathione peroxidase (see Table II ) indicates that when peroxides were low, but not totally absent, the 20:5 caused inactivation of the cyclooxygenase with little oxygenation occurring. An interesting possibility derives from these results. When peroxide tone is extremely low, 20:5 will be a reversible competitive inhibitor of arachidonate conversion to prostaglandins.
However, when a slight elevation in peroxide levels occurs -perhaps via rapid 20:4 oxygenation to PGGzthen the 20:5 becomes also an irreversible inactivator which could very effectively suppress the 20:4 oxidation. The ability to inactivate the cyclooxygenase with little or no detectable oxygen consumption in our assay system is similar to results obtained with acetylenic analogs (30,311. Apparently small amounts of peroxide are sufficient to allow these acids to promote the self-inactivation (22) that will not occur at all in the absence of peroxides (30,321. Without knowing more about the levels of cyclooxygenase activity and the steady state levels of lipid peroxides, it is difficult to determine whether the (n-3) class of acid and the acetylenic analogs achieve their inhibitory effects in vivo by reversible competitive action or by irreversibly inax vating the cyclooxygenase.
Nevertheless, such acids are clearly inhibitors of the conversion of arachidonate to its products.
Thus, although the proposed beneficial role of dietary eicosapentaenoic acid might lie in forming vasoactive, antiaggregating autacoids, a general inhibitory role encompassing both reversible and irreversible actions appears more likely.
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